Latest Stock Buy or Sell? Make More Informed Decisions!

Disappointing. They contoinue to ramp up their number of beds, but their surgery centres are a wild card. Hang on if you own it. Most of the bad news is behind them, and their number should rise going forward.

Was a past pick. Stock has sold off 52% in the past year, but their growth area is in the U.S. where they just got approval from Georgia. (Analysts' price target: $2.50)

Earnings yesterday were a lot better than expected. They've had a rough year or so. It looks like they've now dealt with their troubled investments and are starting to re-invest their money. One issue is that the payout ratio is very high, around 98%. They will likely do everything they can to protect its high dividend, over 10%. He's waiting to see what'll happen to the payout ratio.

A big turnaround story that continues to grow by acquisition. In a competitive space, but they're innovative and they create synergies from their purchases. They've gone from printing to packaging which will grow. (Analysts' price target: $31.94)

Two of three divisions are in cannabis--the THC and CBD sides are expanding 5x from their current sizes into 2019. They can't get enough product now, because they're very good at extractions, which boast huge margins. They will have a new facility by year's end, and increase their cash flow give times It's trading at 1x sales. They're great at what they do. (no analysts' price target)

(A Past Top Pick on July 26, 2017, Down 6%) Hasn't done much and has disappointed. Its UK division is worth much more than the market gives it credit for.